Billiontoone (NASDAQ:BLLN) SVP Bosch John Roderick Ten Sells 1,417 Shares

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,417 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00. Following the transaction, the senior vice president owned 26,467 shares of the company’s stock, valued at approximately $2,646,700. This represents a 5.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total value of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total value of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The stock was sold at an average price of $101.47, for a total value of $287,363.04.

Billiontoone Stock Performance

Shares of NASDAQ BLLN opened at $95.15 on Friday. The stock has a 50 day moving average price of $115.34 and a 200 day moving average price of $95.29. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $150.44. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The stock has a market capitalization of $4.49 billion and a PE ratio of 135.93.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The firm had revenue of $109.45 million for the quarter. Analysts predict that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Guggenheim began coverage on shares of Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 price target for the company. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. BTIG Research lowered their price objective on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 6th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Billiontoone presently has a consensus rating of “Moderate Buy” and an average target price of $126.71.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Rossby Financial LCC bought a new stake in Billiontoone in the 4th quarter valued at $25,000. Wells Fargo & Company MN bought a new stake in shares of Billiontoone during the fourth quarter worth approximately $76,000. Smartleaf Asset Management LLC acquired a new position in shares of Billiontoone in the fourth quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in shares of Billiontoone in the fourth quarter valued at approximately $82,000. Finally, Caitong International Asset Management Co. Ltd bought a new position in shares of Billiontoone during the fourth quarter worth approximately $230,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.